The vaccine is registered "on conditions", in accordance with the procedure established by the Decree of the Government of the Russian Federation No. 441.
Registration was carried out based on the results of clinical trials, during which the drug showed efficacy and safety in volunteers. Clinical trials of the vaccine took place in June-August 2020 at the Sechenov University of the Ministry of Health of Russia.
Source: website of the Ministry of Health of the Russian Federation
